Basilea Pharmaceutica AG (LON: 0QNA)
London
· Delayed Price · Currency is GBP · Price in CHF 39.55
-0.35 (-0.88%)
Jan 22, 2025, 5:33 PM BST
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 428.91 million as of January 23, 2025. Its market cap has increased by 5.64% in one year.
Market Cap
428.91M
Enterprise Value
473.18M
Revenue
131.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
39.55
Market Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 231.10M to 428.91M, an increase of 85.59%. That is a compound annual growth rate of 3.01%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.37B |
| GSK plc | 55.25B |
| Haleon | 33.81B |
| Smith & Nephew | 8.96B |
| ConvaTec Group | 4.94B |
| Hikma Pharmaceuticals | 4.62B |
| HUTCHMED (China) | 1.99B |
| Oxford Nanopore Technologies | 1.42B |